α1-抗胰凝乳蛋白酶 来源于人血浆

ACT, AACT, SERPINA3, Alpha 1-ACT, A1ACT'

np001162-25μg

25μg

BioReagent

≥95%(SDS-PAGE)

急性期血浆蛋白含量为每100毫升45毫克。ACT作为胰凝乳蛋白酶样丝氨酸蛋白酶的特异性抑制剂发挥作用。临床上，它在炎症、一些恶性肿瘤、克罗恩病、溃疡性结肠炎和烧伤中升高。PSA-ACT复合物水平被认为是癌症前列腺的生物标志物。 消光系数：0.6 所用血浆经 FDA 要求的检测显示，乙型肝炎表面抗原（HBsAg）、抗丙型肝炎病毒（抗 - HCV）、抗乙型肝炎核心抗体（抗 - HBc）均为阴性，且抗人类免疫缺陷病毒 1 型和 2 型（抗 - HIV 1 & 2）也为阴性。 An acute-phase plasma protein found at 45 mg per 100 ml. ACT functions as a specific inhibitor of chymotrypsin-like serine proteases. Clinically, it is elevated in inflammatory conditions, some malignancies, Crohn's disease, ulcerative colitis, and burn injuries. The PSA-ACT complex level is considered a biomarker for prostate cancer. Extinction Coefficient: 0.6 Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.

Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2. Post-translational: N- and O-glycosylated.

天然

64 kDa

人(Human)